{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:25:51Z","timestamp":1792725951843,"version":"4.5.0"},"reference-count":96,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1093\/brain\/awp282","type":"journal-article","created":{"date-parts":[[2009,11,11]],"date-time":"2009-11-11T00:15:04Z","timestamp":1257898504000},"page":"172-188","source":"Crossref","is-referenced-by-count":194,"title":["Brain \u03b1-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation"],"prefix":"10.1093","volume":"133","author":[{"given":"Junchao","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Guttman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee C.","family":"Ang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysia S.","family":"Forno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunobu","family":"Shimadzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Rajput","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred D.","family":"Muenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Kish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleh","family":"Hornykiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiaki","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,11,10]]},"reference":[{"key":"key\n\t\t\t\t20170508034240_B1","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0166-2236(00)01794-X","article-title":"New insights into progressive supranuclear palsy","volume":"24","author":"Albers","year":"2001","journal-title":"Trends Neurosci"},{"key":"key\n\t\t\t\t20170508034240_B2","doi-asserted-by":"crossref","first-page":"29739","DOI":"10.1074\/jbc.M600933200","article-title":"Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease","volume":"281","author":"Anderson","year":"2006","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170508034240_B3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2990.2008.00937.x","article-title":"The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease","volume":"34","author":"Attems","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key\n\t\t\t\t20170508034240_B4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour","year":"2008","journal-title":"Neurodegener Dis"},{"key":"key\n\t\t\t\t20170508034240_B5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1750-3639.2008.00171.x","article-title":"Analysis of gene expression in Parkinson's disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death","volume":"19","author":"Bossers","year":"2009","journal-title":"Brain Pathol"},{"key":"key\n\t\t\t\t20170508034240_B6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20170508034240_B7","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","article-title":"Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease","volume":"114","author":"Braak","year":"2007","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170508034240_B8","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","article-title":"A critical evaluation of the Braak staging scheme for Parkinson's disease","volume":"64","author":"Burke","year":"2008","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508034240_B9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/nbdi.2000.0286","article-title":"Accumulation of insoluble alpha-synuclein in dementia with Lewy bodies","volume":"7","author":"Campbell","year":"2000","journal-title":"Neurobiol Dis"},{"key":"key\n\t\t\t\t20170508034240_B10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1046\/j.1471-4159.2001.00021.x","article-title":"The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease","volume":"76","author":"Campbell","year":"2001","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170508034240_B11","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/mds.21007","article-title":"Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients","volume":"21","author":"Chiba-Falek","year":"2006","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508034240_B12","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1097\/00001756-200109170-00017","article-title":"Co-association of parkin and alpha-synuclein","volume":"12","author":"Choi","year":"2001","journal-title":"Neuroreport"},{"key":"key\n\t\t\t\t20170508034240_B13","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2990.2006.00722.x","article-title":"Comparative study of commercially available anti-alpha-synuclein antibodies","volume":"32","author":"Croisier","year":"2006","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key\n\t\t\t\t20170508034240_B14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0002-9440(10)65220-0","article-title":"Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid","volume":"155","author":"Culvenor","year":"1999","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170508034240_B15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/01.jnen.0000205145.54457.ea","article-title":"Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies","volume":"65","author":"Deramecourt","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170508034240_B16","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1074\/jbc.M710012200","article-title":"Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain","volume":"283","author":"Devi","year":"2008","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170508034240_B17","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0002-9440(10)65226-1","article-title":"Widespread alterations of alpha-synuclein in multiple system atrophy","volume":"155","author":"Dickson","year":"1999","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170508034240_B18","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1093\/jnen\/59.9.830","article-title":"Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy","volume":"59","author":"Duda","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170508034240_B19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ana.10279","article-title":"Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases","volume":"52","author":"Duda","year":"2002","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508034240_B20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","article-title":"Comparison of kindreds with Parkinsonism and alpha-synuclein genomic multiplications","volume":"55","author":"Farrer","year":"2004","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508034240_B21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","article-title":"Neuropathology of Parkinson's disease","volume":"55","author":"Forno","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170508034240_B22","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1096\/fj.07-9348com","article-title":"Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain","volume":"22","author":"Fuchs","year":"2008","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20170508034240_B23","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.10175","article-title":"Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia","volume":"51","author":"Furukawa","year":"2002","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508034240_B24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/ana.10207","article-title":"Brain proteasomal function in sporadic Parkinson's disease and related disorders","volume":"51","author":"Furukawa","year":"2002","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508034240_B25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-510X(98)00304-9","article-title":"Consensus statement on the diagnosis of multiple system atrophy","volume":"163","author":"Gilman","year":"1999","journal-title":"J Neurol Sci"},{"key":"key\n\t\t\t\t20170508034240_B26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/sj.mp.4000458","article-title":"Lewy body diseases and multiple system atrophy as alpha-synucleinopathies","volume":"3","author":"Goedert","year":"1998","journal-title":"Mol Psychiatry"},{"key":"key\n\t\t\t\t20170508034240_B27","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1093\/nar\/gkn084","article-title":"Elevated alpha-synuclein mRNA levels in individual UV-laser-microdissected dopaminergic substantia nigra neurons in idiopathic Parkinson's disease","volume":"36","author":"Grundemann","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"key\n\t\t\t\t20170508034240_B28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s004010051177","article-title":"Distinctive neuropathology revealed by alpha-synuclein antibodies in hereditary Parkinsonism and dementia linked to chromosome 4p","volume":"99","author":"Gwinn-Hardy","year":"2000","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170508034240_B29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2990.2001.00345.x","article-title":"Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease","volume":"27","author":"Hishikawa","year":"2001","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key\n\t\t\t\t20170508034240_B30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/00005072-199608000-00004","article-title":"Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system","volume":"55","author":"Irizarry","year":"1996","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170508034240_B31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-X","article-title":"The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170508034240_B32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0304-3940(99)00411-5","article-title":"Epitope mapping of LB509, a monoclonal antibody directed against human alpha-synuclein","volume":"269","author":"Jakes","year":"1999","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170508034240_B33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0014-5793(94)00395-5","article-title":"Identification of two distinct synucleins from human brain","volume":"345","author":"Jakes","year":"1994","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20170508034240_B34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00401-003-0725-y","article-title":"Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution\u2014a pilot study","volume":"106","author":"Jellinger","year":"2003","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170508034240_B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","article-title":"A critical reappraisal of current staging of Lewy-related pathology in human brain","volume":"116","author":"Jellinger","year":"2008","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170508034240_B36","first-page":"253","volume":"112","author":"Jellinger","year":"2006","journal-title":"Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol"},{"key":"key\n\t\t\t\t20170508034240_B37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/embo-reports\/kvf109","article-title":"Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes","volume":"3","author":"Kahle","year":"2002","journal-title":"EMBO Rep"},{"key":"key\n\t\t\t\t20170508034240_B38","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0002-9440(10)63072-6","article-title":"Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model","volume":"159","author":"Kahle","year":"2001","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170508034240_B39","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","article-title":"The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein staging","volume":"34","author":"Kalaitzakis","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key\n\t\t\t\t20170508034240_B40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/mds.10683","article-title":"Alteration in alpha-synuclein mRNA expression in Parkinson's disease","volume":"19","author":"Kingsbury","year":"2004","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508034240_B41","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications","volume":"318","author":"Kish","year":"1988","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170508034240_B42","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508034240_B43","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00401-005-0027-7","article-title":"Clinical and biochemical correlates of insoluble alpha-synuclein in dementia with Lewy bodies","volume":"111","author":"Klucken","year":"2006","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170508034240_B44","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/mds.22207","article-title":"Nigral burden of alpha-synuclein correlates with striatal dopamine deficit","volume":"23","author":"Kovacs","year":"2008","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508034240_B45","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1523\/JNEUROSCI.4564-06.2007","article-title":"Presynaptic alpha-synuclein aggregates, not Lewy bodies, cause neurodegeneration in dementia with Lewy bodies","volume":"27","author":"Kramer","year":"2007","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170508034240_B46","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1006\/exnr.1998.6975","article-title":"Novel alpha-synuclein-immunoreactive proteins in brain samples from the Contursi kindred, Parkinson's, and Alzheimer's disease","volume":"154","author":"Langston","year":"1998","journal-title":"Exp Neurol"},{"key":"key\n\t\t\t\t20170508034240_B47","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1073\/pnas.0406976102","article-title":"Aggregation promoting C-terminal truncation of alpha-synuclein is a normal cellular process and is enhanced by the familial Parkinson's disease-linked mutations","volume":"102","author":"Li","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170508034240_B48","doi-asserted-by":"crossref","first-page":"22670","DOI":"10.1074\/jbc.M501508200","article-title":"A precipitating role for truncated alpha-synuclein and the proteasome in alpha-synuclein aggregation: implications for pathogenesis of Parkinson disease","volume":"280","author":"Liu","year":"2005","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170508034240_B49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0169-328X(91)90043-W","article-title":"The rat brain synucleins; family of proteins transiently associated with neuronal membrane","volume":"11","author":"Maroteaux","year":"1991","journal-title":"Brain Res Mol Brain Res"},{"key":"key\n\t\t\t\t20170508034240_B50","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1523\/JNEUROSCI.23-07-02564.2003","article-title":"Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons","volume":"23","author":"Mash","year":"2003","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170508034240_B51","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508034240_B52","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1471-4159.2005.03145.x","article-title":"DJ-1 is present in a large molecular complex in human brain tissue and interacts with alpha-synuclein","volume":"93","author":"Meulener","year":"2005","journal-title":"J Neurochem"},{"key":"key\n\t\t\t\t20170508034240_B53","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1212\/01.WNL.0000127517.33208.F4","article-title":"Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication","volume":"62","author":"Miller","year":"2004","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508034240_B54","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.expneurol.2008.06.004","article-title":"Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration","volume":"213","author":"Mollenhauer","year":"2008","journal-title":"Exp Neurol"},{"key":"key\n\t\t\t\t20170508034240_B55","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00401-007-0316-4","article-title":"alpha-Synuclein pathology in the neostriatum in Parkinson's disease","volume":"115","author":"Mori","year":"2008","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170508034240_B56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00401-002-0555-3","article-title":"Lewy bodies in progressive supranuclear palsy","volume":"104","author":"Mori","year":"2002","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170508034240_B57","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ana.410430612","article-title":"Hereditary form of Parkinsonism\u2014dementia","volume":"43","author":"Muenter","year":"1998","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508034240_B58","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awn349","article-title":"Detection of elevated levels of soluble alpha-synuclein oligomers in post-mortem brain extracts from patients with dementia with Lewy bodies","volume":"132","author":"Paleologou","year":"2009","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508034240_B59","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/mds.21466","article-title":"Expression of alpha-synuclein mRNA in Parkinson's disease","volume":"22","author":"Papapetropoulos","year":"2007","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508034240_B60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-510X(89)90219-0","article-title":"Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)","volume":"94","author":"Papp","year":"1989","journal-title":"J Neurol Sci"},{"issue":"Pt 2","key":"key\n\t\t\t\t20170508034240_B61","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/brain\/117.2.235","article-title":"The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology","volume":"117","author":"Papp","year":"1994","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508034240_B62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.20321","article-title":"Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia","volume":"57","author":"Parkkinen","year":"2005","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508034240_B63","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","article-title":"Applicability of current staging\/categorization of alpha-synuclein pathology and their clinical relevance","volume":"115","author":"Parkkinen","year":"2008","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170508034240_B64","doi-asserted-by":"crossref","first-page":"48120","DOI":"10.1074\/jbc.M306889200","article-title":"Novel monoclonal antibodies demonstrate biochemical variation of brain parkin with age","volume":"278","author":"Pawlyk","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170508034240_B65","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0304-3940(03)00781-X","article-title":"Epitope mapping and specificity of the anti-alpha-synuclein monoclonal antibody Syn-1 in mouse brain and cultured cell lines","volume":"349","author":"Perrin","year":"2003","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170508034240_B66","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.neurobiolaging.2004.10.006","article-title":"Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases","volume":"26","author":"Pletnikova","year":"2005","journal-title":"Neurobiol Aging"},{"key":"key\n\t\t\t\t20170508034240_B67","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson's disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"key\n\t\t\t\t20170508034240_B68","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF03033778","article-title":"Alpha B-crystallin is a major component of glial cytoplasmic inclusions in multiple system atrophy","volume":"7","author":"Pountney","year":"2005","journal-title":"Neurotox Res"},{"key":"key\n\t\t\t\t20170508034240_B69","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0006-8993(01)02772-X","article-title":"Altered expression of the synuclein family mRNA in Lewy body and Alzheimer's disease","volume":"914","author":"Rockenstein","year":"2001","journal-title":"Brain Res"},{"key":"key\n\t\t\t\t20170508034240_B70","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9440(10)63633-4","article-title":"Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies","volume":"163","author":"Sampathu","year":"2003","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170508034240_B71","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0896-6273(03)00024-2","article-title":"The formation of highly soluble oligomers of alpha-synuclein is regulated by fatty acids and enhanced in Parkinson's disease","volume":"37","author":"Sharon","year":"2003","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20170508034240_B72","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/mds.22306","article-title":"Expression of Lewy body protein septin 4 in postmortem brain of Parkinson's disease and control subjects","volume":"24","author":"Shehadeh","year":"2009","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508034240_B73","article-title":"Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology","author":"Simunovic","year":"2008","journal-title":"Brain"},{"key":"key\n\t\t\t\t20170508034240_B74","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1090278","article-title":"alpha-Synuclein locus triplication causes Parkinson's disease","volume":"302","author":"Singleton","year":"2003","journal-title":"Science"},{"key":"key\n\t\t\t\t20170508034240_B75","doi-asserted-by":"crossref","first-page":"11753","DOI":"10.1074\/jbc.M208641200","article-title":"Aggregated and monomeric alpha-synuclein bind to the S6' proteasomal protein and inhibit proteasomal function","volume":"278","author":"Snyder","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170508034240_B76","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0304-3940(98)00504-7","article-title":"Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies","volume":"251","author":"Spillantini","year":"1998","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170508034240_B77","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170508034240_B78","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170508034240_B79","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/mds.20391","article-title":"Alpha-synuclein mRNA expression in sporadic Parkinson's disease","volume":"20","author":"Tan","year":"2005","journal-title":"Mov Disord"},{"key":"key\n\t\t\t\t20170508034240_B80","doi-asserted-by":"crossref","first-page":"44405","DOI":"10.1074\/jbc.M308041200","article-title":"Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function","volume":"278","author":"Tofaris","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170508034240_B81","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ana.10814","article-title":"Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy","volume":"55","author":"Tong","year":"2004","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508034240_B82","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2990.2007.00907.x","article-title":"Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy","volume":"33","author":"Trojanowski","year":"2007","journal-title":"Neuropathol Appl Neurobiol"},{"key":"key\n\t\t\t\t20170508034240_B83","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1212\/WNL.57.9.1675","article-title":"Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls","volume":"57","author":"Tsuboi","year":"2001","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508034240_B84","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/ana.410440324","article-title":"Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble alpha-synuclein","volume":"44","author":"Tu","year":"1998","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508034240_B85","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.jnen.0000218449.17073.43","article-title":"Lewy bodies in progressive supranuclear palsy represent an independent disease process","volume":"65","author":"Uchikado","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"key\n\t\t\t\t20170508034240_B86","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.90.23.11282","article-title":"Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease","volume":"90","author":"Ueda","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170508034240_B87","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2353\/ajpath.2006.050770","article-title":"Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies","volume":"168","author":"Uryu","year":"2006","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t20170508034240_B88","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0304-3940(97)00891-4","article-title":"NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease","volume":"239","author":"Wakabayashi","year":"1997","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170508034240_B89","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-3940(98)00407-8","article-title":"Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy","volume":"249","author":"Wakabayashi","year":"1998","journal-title":"Neurosci Lett"},{"key":"key\n\t\t\t\t20170508034240_B90","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ana.410350110","article-title":"Autosomal dominant Lewy body Parkinsonism in a four-generation family","volume":"35","author":"Waters","year":"1994","journal-title":"Ann Neurol"},{"key":"key\n\t\t\t\t20170508034240_B91","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00401-008-0375-1","article-title":"Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusions","volume":"116","author":"Waxman","year":"2008","journal-title":"Acta Neuropathol"},{"key":"key\n\t\t\t\t20170508034240_B92","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"key\n\t\t\t\t20170508034240_B93","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1212\/WNL.47.3.718","article-title":"Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease","volume":"47","author":"Wilson","year":"1996","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20170508034240_B94","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1523\/JNEUROSCI.14-05-02966.1994","article-title":"Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration","volume":"14","author":"Wilson","year":"1994","journal-title":"J Neurosci"},{"key":"key\n\t\t\t\t20170508034240_B95","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/nm0602-600","article-title":"Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease","volume":"8","author":"Xu","year":"2002","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20170508034240_B96","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","article-title":"Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort","volume":"70","author":"Zaccai","year":"2008","journal-title":"Neurology"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/133\/1\/172\/16695889\/awp282.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T11:42:06Z","timestamp":1590234126000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article-lookup\/doi\/10.1093\/brain\/awp282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,10]]},"references-count":96,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,11,10]]},"published-print":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awp282","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.2456979.2093081","asserted-by":"object"}]},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11,10]]}}}